Survodutide, a glucagon receptor/glucagon-like peptide-1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo-controlled, dose-finding, phase 2 trial.

Autor: le Roux CW; St. Vincent's University Hospital and University College Dublin, Dublin, Ireland., Steen O; Private practice, Toronto, Ontario, Canada., Lucas KJ; Diabetes and Endocrinology Consultants, Morehead City, North Carolina, USA., Ekinci EI; Austin Health, Heidelberg, Victoria, Australia.; The Australian Centre for Accelerating Diabetes Innovation, University of Melbourne, Parkville, Victoria, Australia.; Department of Medicine, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia., Startseva E; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Unseld A; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Hussain SA; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Hennige AM; Boehringer Ingelheim International GmbH, Biberach, Germany.
Jazyk: angličtina
Zdroj: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Nov 25. Date of Electronic Publication: 2024 Nov 25.
DOI: 10.1111/dom.16052
Databáze: MEDLINE